AbuAlrob, Hajar
Ioannidis, George
Jaglal, Susan
Costa, Andrew
Grifith, Lauren E.
Thabane, Lehana
Adachi, Jonathan D.
Cameron, Cathy
Hillier, Loretta
Lau, Arthur
Papaioannou, Alexandra
Funding for this research was provided by:
Ontario Ministry of Health and Long-Term Care
Article History
Received: 30 November 2023
Accepted: 24 April 2024
First Online: 25 June 2024
Declarations
:
: The authors Hajar AbuAlrob declare that they have no conflict of interest, George Ioannidis declares that they have no conflict of interest, Susan Jaglal declares that they have no conflict of interest Andrew Costa declares that they have no conflict of interest, Lauren E. Grifith declares that they have no conflict of interest, Lehana Thabane declares that they have no conflict of interest, Cathy Cameron declares that they have no conflict of interest, Loretta Hillier declares that they have no conflict of interest, and Arthur Lau, declares that they have no conflict of interest. Jonathan D. Adachi received Honoraria from Amgen and Paladin; advisory board Amgen, Paladin (speaker), Gilead (speaker); clinical trials Amgen and Radius. Alexandra Papaioannou received Amgen grants/Research support Amgen, Ontario College of Family Physicians Honoraria/Consulting fees; Amgen, Paladin Speakers Bureau; Other support from McMaster University, Osteoporosis Canada, CABHI, Ontario College of Family Physicians, CIHR.